Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy

Bernt Johan Due-Tønnessen; Arild Egge; Tryggve Lundar; Bård Krossnes; Einar Stensvold; Paulina Due-Tønnessen; Petter Brandal

doi:10.1186/s40064-015-1178-1

Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy

Springerplus. 2015 Aug 2:4:389. doi: 10.1186/s40064-015-1178-1. eCollection 2015.

Authors

Bernt Johan Due-Tønnessen¹, Arild Egge¹, Tryggve Lundar¹, Bård Krossnes², Einar Stensvold³, Paulina Due-Tønnessen⁴, Petter Brandal⁵

Affiliations

¹ Department of Neurosurgery, Oslo University Hospital, Postboks 4950, Nydalen, 0424 Oslo, Norway.
² Department of Pathology, Oslo University Hospital, Oslo, Norway.
³ Department of Pediatrics, Oslo University Hospital, Oslo, Norway.
⁴ Department of Radiology, Oslo University Hospital, Oslo, Norway.
⁵ Department of Oncology, Oslo University Hospital, Oslo, Norway.

Abstract

We report on an infant who underwent gross total resection (GTR) of a posterior fossa ependymoblastoma in the second month of life followed by chemotherapy with uneventful long-term survival for 12 years. Postoperative radiotherapy has been considered obligate to have a chance for prolonged survival, but is inadvisable in infants. To our knowledge, this is the first reported long-term survival in an infant treated for ependymoblastoma.

Keywords: Long-term survival; Pediatric neurosurgery; Posterior fossa ependymoblastoma.